Clinical Research Directory
Browse clinical research sites, groups, and studies.
Analysis of Circulating Tumor mArkers in Blood 4 - ALCINA 4
Sponsor: Institut Curie
Summary
Multi-cohort exploratory prospective study. Participation in the ALCINA 4 study does not change the standard management of the patient, including the treatments administered. A sampling schedule will be set up for each cohort. Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 12 or 18 months. If a specific tumor sample is required, it will be collected only once during the study.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
2050
Start Date
2022-05-19
Completion Date
2031-06-01
Last Updated
2025-11-24
Healthy Volunteers
No
Conditions
Interventions
Blood sample
Depending on the clinical context studied and the biomarkers studied and/or sought, the timing of blood samples will vary between cohorts. There may be up to 4 samples taken per patient for up to 24 months.
Biopsy
If a specific tumor sample is required, it will be collected only once during the study
Locations (2)
Institut Curie
Paris, France
Institut Curie
Saint-Cloud, France